Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Clinical & Experimental Metastasis
|
February 22, 2011
c-Crk proto-oncogene contributes to transcriptional repression of p120-catenin in non-small cell lung cancer cells
Fariborz Mortazavi, Steven Dubinett, Matthew Rettig
Advances in Experimental Medicine and Biology
|
February 16, 2020
CCL21 Programs Immune Activity in Tumor Microenvironment
Sherven Sharma, Pournima Kadam, Steven Dubinett
Oncoimmunology
|
December 25, 2012
Targeting MDSCs enhance therapeutic vaccination responses against lung cancer
Minu K Srivastava, Steven Dubinett, Sherven Sharma
Molecular Cancer Research : MCR
|
May 13, 2010
p120-catenin is transcriptionally downregulated by FOXC2 in non-small cell lung cancer cells
Fariborz Mortazavi, Jiabin An, Steven Dubinett, et al.
Seminars in Oncology
|
July 19, 2022
Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer
Daniel Sanghoon Shin, Kevin Park, Edward Garon, et al.
Cancer Research
|
September 18, 2004
Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer
Kostyantyn Krysan, Harnisha Dalwadi, Sherven Sharma, et al.
Microbes and Infection
|
November 22, 2005
COX-2 inhibition affects growth rate of Chlamydia muridarum within epithelial cells
Wei Liu, Steven Dubinett, Simie Lavern A Patterson, et al.
American Journal of Cancer Research
|
August 27, 2013
Effect of epigenetic histone modifications on E-cadherin splicing and expression in lung cancer
Wei Liao, Gwen Jordaan, Minu K Srivastava, et al.
Journal of Clinical Pharmacology
|
November 5, 2002
Respiratory and immunologic consequences of marijuana smoking
Donald P Tashkin, Gayle C Baldwin, Theodore Sarafian, et al.
Expert Opinion on Biological Therapy
|
June 30, 2011
MUC1 peptide vaccine mediated antitumor activity in non-small cell lung cancer
Sherven Sharma, Minu K Srivastava, Marni Harris-White, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Clinical & Experimental Metastasis
|
February 22, 2011
c-Crk proto-oncogene contributes to transcriptional repression of p120-catenin in non-small cell lung cancer cells
Fariborz Mortazavi, Steven Dubinett, Matthew Rettig
Advances in Experimental Medicine and Biology
|
February 16, 2020
CCL21 Programs Immune Activity in Tumor Microenvironment
Sherven Sharma, Pournima Kadam, Steven Dubinett
Oncoimmunology
|
December 25, 2012
Targeting MDSCs enhance therapeutic vaccination responses against lung cancer
Minu K Srivastava, Steven Dubinett, Sherven Sharma
Molecular Cancer Research : MCR
|
May 13, 2010
p120-catenin is transcriptionally downregulated by FOXC2 in non-small cell lung cancer cells
Fariborz Mortazavi, Jiabin An, Steven Dubinett, et al.
Seminars in Oncology
|
July 19, 2022
Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer
Daniel Sanghoon Shin, Kevin Park, Edward Garon, et al.
Cancer Research
|
September 18, 2004
Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer
Kostyantyn Krysan, Harnisha Dalwadi, Sherven Sharma, et al.
Microbes and Infection
|
November 22, 2005
COX-2 inhibition affects growth rate of Chlamydia muridarum within epithelial cells
Wei Liu, Steven Dubinett, Simie Lavern A Patterson, et al.
American Journal of Cancer Research
|
August 27, 2013
Effect of epigenetic histone modifications on E-cadherin splicing and expression in lung cancer
Wei Liao, Gwen Jordaan, Minu K Srivastava, et al.
Journal of Clinical Pharmacology
|
November 5, 2002
Respiratory and immunologic consequences of marijuana smoking
Donald P Tashkin, Gayle C Baldwin, Theodore Sarafian, et al.
Expert Opinion on Biological Therapy
|
June 30, 2011
MUC1 peptide vaccine mediated antitumor activity in non-small cell lung cancer
Sherven Sharma, Minu K Srivastava, Marni Harris-White, et al.
Page
of 4